Versant Venture Capital VI, L.P. - 10%+ Owner at LENZ Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
LENZ on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Versant Venture Capital VI, L.P. - trading volume in the past year for LENZ Therapeutics, Inc.

Holdings reported by Versant Venture Capital VI, L.P. for LENZ Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.05M $49.4M $47.01 Sep 30, 2025 Direct
Common Stock 764K $35.9M $47.01 Sep 30, 2025 Indirect

Transactions reported by Versant Venture Capital VI, L.P. for LENZ Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.